Cargando…
Clinical Benefit of Antiviral Agents for Hepatocellular Carcinoma Patients With Low Preoperative HBV-DNA Loads Undergoing Curative Resection: A Meta-Analysis
BACKGROUND AND AIMS: The clinical benefit of adjuvant antiviral therapy after curative therapy for HCC in patients with high preoperative HBV-DNA loads has been studied widely but that in patients with low preoperative HBV-DNA loads remains controversial. The purpose of this study was to determine t...
Autores principales: | Liu, Kai-Xuan, Hong, Jian-Guo, Wu, Rui, Dong, Zhao-Ru, Yang, Ya-Fei, Yan, Yu-Chuan, Yang, Chun-Cheng, Yan, Lun-Jie, Yao, Sheng-Yu, Li, Hai-Chao, Zhi, Xu-Ting, Li, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933452/ https://www.ncbi.nlm.nih.gov/pubmed/33680960 http://dx.doi.org/10.3389/fonc.2021.605648 |
Ejemplares similares
-
Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection
por: Chen, Jian-Lin, et al.
Publicado: (2016) -
Prognostic value of preoperative computed tomography in HBV-related hepatocellular carcinoma patients after curative resection
por: Zhang, Wei, et al.
Publicado: (2019) -
Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative Resection
por: Lin, Yen-Po, et al.
Publicado: (2021) -
HBV-DNA Load-Related Peritumoral Inflammation and ALBI Scores Predict HBV Associated Hepatocellular Carcinoma Prognosis after Curative Resection
por: Liao, Rui, et al.
Publicado: (2018) -
Preoperative ALBI grade predicts the outcomes in non-B non-C HCC patients undergoing primary curative resection
por: Tsai, Yu-Chieh, et al.
Publicado: (2021)